Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tocagen Inc (TOCA)

Tocagen Inc (TOCA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,138
  • Shares Outstanding, K 23,919
  • Annual Sales, $ 40 K
  • Annual Income, $ -63,520 K
  • 60-Month Beta 0.01
  • Price/Sales 870.39
  • Price/Cash Flow N/A
  • Price/Book 14.48
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.68
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/05/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.72
  • Growth Rate Est. (year over year) +138,850.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1500 +9.57%
on 05/18/20
1.8700 -32.62%
on 06/10/20
+0.0800 (+6.78%)
since 05/15/20
3-Month
0.9248 +36.25%
on 04/03/20
1.8700 -32.62%
on 06/10/20
-0.3800 (-23.17%)
since 03/13/20
52-Week
0.4220 +198.58%
on 12/18/19
6.7700 -81.39%
on 07/01/19
-4.5300 (-78.24%)
since 06/14/19

Most Recent Stories

More News
Oncopeptides Announces Leadership Changes: Jakob Lindberg Assumes a New Role as CSO, and Marty J Duvall is Appointed CEO

, /PRNewswire/ -- announces that the Board of Directors has appointed Marty J Duvall as Chief Executive Officer, CEO. Marty J Duvall replaces who has been CEO since the restart of the company in 2011....

LIND : 8.11 (-2.05%)
TOCA : 1.2600 (-3.82%)
Forte Biosciences, Inc. Announces Closing of Merger With Tocagen

Forte Biosciences, Inc. (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced merger with Tocagen Inc. (previously trading on NASDAQ under...

TOCA : 1.2600 (-3.82%)
FBRX : 15.03 (+0.40%)
Tocagen Announces Change to Virtual Format for Special Meeting of Stockholders

, /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), historically a clinical-stage, cancer-selective gene therapy company, announced today that, due to public health and safety concerns related to the COVID-19...

TOCA : 1.2600 (-3.82%)
Tocagen Reports First Quarter 2020 Financial Results

Tocagen Inc. (Nasdaq: TOCA), historically a clinical-stage, cancer-selective gene therapy company, today reported financial results for the first quarter ended March 31, 2020.

TOCA : 1.2600 (-3.82%)
Thinking about buying stock in Aphria, Chesapeake Energy Corp, JetBlue Airways, Tocagen, or Verizon?

InvestorsObserver issues critical PriceWatch Alerts for APHA, CHK, JBLU, TOCA, and VZ.

APHA : 5.15 (+1.58%)
CHK : 11.85 (-7.28%)
JBLU : 11.08 (-4.07%)
TOCA : 1.2600 (-3.82%)
VZ : 55.60 (+0.98%)
Tocagen Reports Fourth Quarter and Full Year 2019 Financial Results

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results and business highlights for the fourth quarter and full year ended December 31, 2019....

TOCA : 1.2600 (-3.82%)
Thinking about buying stock in Aurora Cannabis, Barrick Gold Corp, Micron, Sprouts Farmers Market, or Tocagen?

InvestorsObserver issues critical PriceWatch Alerts for ACB, GOLD, MU, SFM, and TOCA.

ACB : 12.26 (-4.74%)
ACB.TO : 16.69 (-3.58%)
ABX : 13.54 (+3.20%)
MU : 50.24 (-0.53%)
SFM : 25.93 (+0.04%)
TOCA : 1.2600 (-3.82%)
Can You Make Money With Penny Stocks? Some Names To Know

CORAL GABLES, FL / ACCESSWIRE / February 21, 2020 / The top website for all things penny stocks, PennyStocks.com just released a new, exclusive & informative article titled: The team at PennyStocks.com...

TOCA : 1.2600 (-3.82%)
Tocagen and Forte Biosciences Announce Merger

Tocagen Inc. (Nasdaq: TOCA), and Forte Biosciences, Inc., a privately held clinical-stage biopharmaceutical company developing a live biotherapeutic for the treatment of inflammatory skin diseases, announced...

TOCA : 1.2600 (-3.82%)
Pharmaceuticals Step Up Their Efforts to Combat the Spread of Cancer

The cancer treatment industry has grown to be one of the largest marketplaces in the world due to the disease's global prevalence. The Centers for Disease Control and Prevention (CDC) estimated that between...

ONPH : 0.0096 (unch)
LPTX : 1.8050 (-0.28%)
DMPI : 0.7000 (+1.45%)
TRIL : 7.53 (-0.79%)
TOCA : 1.2600 (-3.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade TOCA with:

Business Summary

Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company which focuses on retroviral gene therapy platforms. The company's lead product candidate consists of Toca 511 & Toca FC, initially for the treatment of recurrent high grade glioma, a disease with a significant unmet medical need....

See More

Key Turning Points

2nd Resistance Point 1.6067
1st Resistance Point 1.4333
Last Price 1.2600
1st Support Level 1.1533
2nd Support Level 1.0467

See More

52-Week High 6.7700
Fibonacci 61.8% 4.3451
Fibonacci 50% 3.5960
Fibonacci 38.2% 2.8469
Last Price 1.2600
52-Week Low 0.4220

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar